Atopisk eksem

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Atopisk eksem. / Gerner, Trine; Skov, Lone; Thyssen, Jacob Pontoppidan.

In: Ugeskrift for Laeger, Vol. 180, No. 4, V04170331, 2018.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Gerner, T, Skov, L & Thyssen, JP 2018, 'Atopisk eksem', Ugeskrift for Laeger, vol. 180, no. 4, V04170331. <http://ugeskriftet.dk/videnskab/atopisk-eksem>

APA

Gerner, T., Skov, L., & Thyssen, J. P. (2018). Atopisk eksem. Ugeskrift for Laeger, 180(4), [V04170331]. http://ugeskriftet.dk/videnskab/atopisk-eksem

Vancouver

Gerner T, Skov L, Thyssen JP. Atopisk eksem. Ugeskrift for Laeger. 2018;180(4). V04170331.

Author

Gerner, Trine ; Skov, Lone ; Thyssen, Jacob Pontoppidan. / Atopisk eksem. In: Ugeskrift for Laeger. 2018 ; Vol. 180, No. 4.

Bibtex

@article{39c8afa9a15647ee86cf3eb3b82a0912,
title = "Atopisk eksem",
abstract = "Atopic dermatitis is a chronic and relapsing inflammatory skin disease. The clinical features vary among different age and ethnic groups, but pruritus is a hallmark. The treatment of atopic dermatitis includes skin barrier restoration with daily application of moisturizers. Topical corticosteroids and calcineurin inhibitors are first-line treatment for acute flares. In severe cases, immunosuppressive drugs are indicated. Targeted biological drugs are being tested in clinical trials.",
keywords = "Administration, Cutaneous, Adrenal Cortex Hormones/administration & dosage, Calcineurin Inhibitors/administration & dosage, Comorbidity, Dermatitis, Atopic/drug therapy, Dermatologic Agents/administration & dosage, Humans, Immunosuppressive Agents/administration & dosage, Risk Factors",
author = "Trine Gerner and Lone Skov and Thyssen, {Jacob Pontoppidan}",
year = "2018",
language = "Dansk",
volume = "180",
journal = "Ugeskrift for Laeger",
issn = "0041-5782",
publisher = "Almindelige Danske Laegeforening",
number = "4",

}

RIS

TY - JOUR

T1 - Atopisk eksem

AU - Gerner, Trine

AU - Skov, Lone

AU - Thyssen, Jacob Pontoppidan

PY - 2018

Y1 - 2018

N2 - Atopic dermatitis is a chronic and relapsing inflammatory skin disease. The clinical features vary among different age and ethnic groups, but pruritus is a hallmark. The treatment of atopic dermatitis includes skin barrier restoration with daily application of moisturizers. Topical corticosteroids and calcineurin inhibitors are first-line treatment for acute flares. In severe cases, immunosuppressive drugs are indicated. Targeted biological drugs are being tested in clinical trials.

AB - Atopic dermatitis is a chronic and relapsing inflammatory skin disease. The clinical features vary among different age and ethnic groups, but pruritus is a hallmark. The treatment of atopic dermatitis includes skin barrier restoration with daily application of moisturizers. Topical corticosteroids and calcineurin inhibitors are first-line treatment for acute flares. In severe cases, immunosuppressive drugs are indicated. Targeted biological drugs are being tested in clinical trials.

KW - Administration, Cutaneous

KW - Adrenal Cortex Hormones/administration & dosage

KW - Calcineurin Inhibitors/administration & dosage

KW - Comorbidity

KW - Dermatitis, Atopic/drug therapy

KW - Dermatologic Agents/administration & dosage

KW - Humans

KW - Immunosuppressive Agents/administration & dosage

KW - Risk Factors

M3 - Tidsskriftartikel

C2 - 29393034

VL - 180

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

IS - 4

M1 - V04170331

ER -

ID: 219535539